The Division of Rheumatology, Department of Internal Medicine has recruited a new co-director of the Scleroderma Program, one of the largest scleroderma clinical and research programs in the world.
An internationally known researcher and clinician in scleroderma (systemic sclerosis), Zsuzsanna McMahan, MD, MHS, joined McGovern Medical School from Johns Hopkins University, where she was a faculty member for 11 years.
In addition to her appointment as co-director of the Scleroderma Program alongside Shervin Assassi, MD, and Maureen Mayes, MD, McMahan is an associate professor of medicine and will be involved in mentoring junior faculty.